Overview Fundamentals API Earnings EOD API Sample Code Pricing

Intracellular Th (ITCI NASDAQ) stock market data APIs

$78.1 -0.59(-0.7%) as of July 15, 2024
Price chart is built with Anychart

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment of various depressive disorders, as well as additional neuropsychiatric indications. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease, CNS, and other disorders; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression, anxiety, and sleep disorders. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

Intracellular Th Financial Data Overview

78.69
78.1
-
79.03
77.57
45.5-84.89
8 308 M
106 M
514 M
-0.16
1.007
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ITCI',
Type: 'Common Stock',
Name: 'Intracellular Th',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0026ZFZC4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1567514',
EmployerIdNumber: '36-4742850',
FiscalYearEnd: 'December',
IPODate: '2014-01-07',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Intracellular Th Fundamental Data is available in our Financial Data APIs

  • Net Revenue 514 M
  • EBITDA -131 415 000
  • Earnings Per Share -1.16
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Intracellular Th Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast -0.32

Get Intracellular Th End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com